Canada Markets open in 5 hrs 51 mins

Applied Therapeutics, Inc. (APLT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.3100+0.1000 (+8.26%)
At close: 04:00PM EDT
1.5000 +0.19 (+14.50%)
After hours: 07:40PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.71
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 319.1400
52 Week Low 30.7280
50-Day Moving Average 31.0906
200-Day Moving Average 34.5706

Share Statistics

Avg Vol (3 month) 3417.34k
Avg Vol (10 day) 3194.57k
Shares Outstanding 526.22M
Implied Shares Outstanding 6N/A
Float 819.19M
% Held by Insiders 120.11%
% Held by Institutions 177.40%
Shares Short (Jul 14, 2022) 4424.06k
Short Ratio (Jul 14, 2022) 40.47
Short % of Float (Jul 14, 2022) 42.36%
Short % of Shares Outstanding (Jul 14, 2022) 41.62%
Shares Short (prior month Jun 14, 2022) 41.34M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-59.07%
Return on Equity (ttm)-117.99%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-104.53M
Diluted EPS (ttm)-4.1350
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)55.65M
Total Cash Per Share (mrq)2.12
Total Debt (mrq)1.23M
Total Debt/Equity (mrq)2.92
Current Ratio (mrq)2.86
Book Value Per Share (mrq)3.31

Cash Flow Statement

Operating Cash Flow (ttm)-92.92M
Levered Free Cash Flow (ttm)-53.79M